Management Change/Compensation Form 8 K

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Merger Incentive Plan

On September 19, 2024, Battalion Oil Corporation (the "Company") adopted a Merger Incentive Plan (the "Plan"), in the form previously authorized and approved by the Company's compensation committee and the board of directors of the Company, to provide for grants of compensatory awards to eligible employees of the Company, including the Company's executive officers (each, a "Participant").

The Plan, which has an end date of December 31, 2025, provides for an Equity Grant Value Pool (further described below), of which a percentage interest maybe granted and allocated in accordance with the Plan and at the discretion of the Company's Chief Executive Officer (the "Administrator") to Participants, in the form of Equity Grant Units. A total of 229,022 Equity Grant Units may be granted and allocated to Participants pursuant to the Plan.

Following the adoption of the Plan, each of the executive officers of the Company named below, entered into individual award agreements, pursuant to the Plan, and the Company allocated and granted to such executive officers, the following: (a) 50,385 Equity Grant Units representing approximately 22% of the Equity Grant Value Pool to Matthew B. Steele; and (b) 18,322 Equity Grant Units representing approximately 8% of the Equity Grant Value Pool, to each of Daniel P. Rohling and Walter R. Mayer.

Subject to the terms and conditions of the Plan, all Equity Grant Units that have been granted and allocated to a Participant under the Plan and that are outstanding as of the closing of a change of control transaction (as further described in the Plan, the "Closing") shall vest upon the date on which the Closing occurs (the "Closing Date"), and shall be payable in a cash lump sum within ten (10) days after the Closing Date; provided, however, that at the Company's election (and subject to applicable regulations), the value of Equity Grant Units may be paid by the Company to the Participants in the form of equity of the same value. The amount payable, pursuant to the Plan, shall be proportionately equal to the percentage of the Equity Grant Value Pool allocated and granted to such Participant.

The maximum aggregate amount of the Equity Grant Value Pool shall be calculated based on the value of all shares of the Company's common stock, par value $0.0001 ("Common Stock"), existing immediately before the Closing (based on (a) the consideration paid for the Company's Common Stock in connection with the Closing; or (b) the closing price of the Company's Common Stock on the date a person or group files a report with the U.S. Securities and Exchange Commission announcing that they are the beneficial owners of more than 50% of the total voting power of the outstanding voting stock of the Company), divided by 16,845,325 and then the result multiplied by 229,022. Under the Plan, a "Closing" shall not be deemed to have occurred due to the beneficial ownership of Common Stock by any person or group that has filed a Schedule 13D on or prior to adoption of the Plan.

Individual awards may be made to eligible Participants selected by the Administrator and may be evidenced by award agreements between the Company and the Participant. Awards granted under the Plan are conditioned upon a Closing occurring on or prior to December 31, 2025; and the Participant's continued employment or service to the Company prior to the Closing or the Participant's termination of employment by the Company other than for Cause (as defined in the Plan) prior to the Closing.

Important Information for Investors and Stockholders

This communication is being made in respect of the proposed transaction involving the Company and Parent. In connection with the proposed transaction, the Company intends to file the relevant materials with the SEC, including a proxy statement on Schedule 14A and a transaction statement on Schedule 13e-3 (the "Schedule 13e-3"). Promptly after filing its definitive proxy statement with the SEC, the Company will mail the definitive proxy statement and a proxy card to each stockholder of the Company entitled to vote at the special meeting relating to the proposed transaction. This communication is not a substitute for the proxy statement, the Schedule 13e-3 or any other document that the Company may file with the SEC or send to its stockholders in connection with the proposed transaction. The materials to be filed by the Company will be made available to the Company's investors and stockholders at no expense to them and copies may be obtained free of charge on the Company's website at www.battalionoil.com. In

2

addition, all of those materials will be available at no charge on the SEC's website at www.sec.gov. Investors and stockholders of the Company are urged to read the proxy statement, the Schedule 13e-3 and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed transaction because they contain important information about the Company and the proposed transaction. The Company and its directors, executive officers, other members of its management and employees may be deemed to be participants in the solicitation of proxies of the Company stockholders in connection with the proposed transaction under SEC rules. Investors and stockholders may obtain more detailed information regarding the names, affiliations and interests of the Company's executive officers and directors in the solicitation by reading the Company's Annual Report on Form 10-K, as amended on Form 10-K/A, for the fiscal year ended December 31, 2023, and the proxy statement, the Schedule 13e-3 and other relevant materials that will be filed with the SEC in connection with the proposed transaction when they become available. Information concerning the interests of the Company's participants in the solicitation, which may, in some cases, be different than those of the Company's stockholders generally, will be set forth in the proxy statement relating to the proposed transaction and the Schedule 13e-3 when they become available.

Forward-Looking Statements

All statements and assumptions in this communication that do not directly and exclusively relate to historical facts could be deemed "forward-looking statements." Forward-looking statements are often identified by the use of words such as "anticipates," "believes," "estimates," "expects," "may," "could," "should," "forecast," "goal," "intends," "objective," "plans," "projects," "strategy," "target" and "will" and similar words and terms or variations of such. These statements represent current intentions, expectations, beliefs or projections, and no assurance can be given that the results described in such statements will be achieved. Forward-looking statements include, among other things, statements about the potential benefits of the proposed transaction; the prospective performance and outlook of the Company's business, performance and opportunities; the ability of the parties to complete the proposed transaction and the expected timing of completion of the proposed transaction; as well as any assumptions underlying any of the foregoing. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of the Company's control. Important factors that could cause actual results to differ materially from those described in forward-looking statements include, but are not limited to, (i) the risk that the proposed transaction may not be completed in a timely manner or at all; (ii) the failure to receive, on a timely basis or otherwise, the required approvals of the proposed transaction by the Company's stockholders; (iii) the possibility that any or all of the various conditions to the consummation of the proposed transaction may not be satisfied or waived, including the failure to receive any required regulatory approvals from any applicable governmental entities (or any conditions, limitations or restrictions placed on such approvals); (iv) the possibility that competing offers or acquisition proposals for the Company will be made; (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the definitive transaction agreement relating to the proposed transaction, including in circumstances, which would require the Company to pay a termination fee; (vi) the effect of the announcement or pendency of the proposed transaction on the Company's ability to attract, motivate or retain key executives and employees, its ability to maintain relationships with its customers, suppliers and other business counterparties, or its operating results and business generally; (vii) risks related to the proposed transaction diverting management's attention from the Company's ongoing business operations; (viii) the amount of costs, fees and expenses related to the proposed transaction; (ix) the risk that the Company's stock price may decline significantly if the Merger is not consummated; (x) the risk of shareholder litigation in connection with the proposed transaction, including resulting expense or delay; and (xi) other factors as set forth from time to time in the Company's filings with the SEC, including its Annual Report on Form 10-K, as amended, for the fiscal year ended December 31, 2023, as may be updated or supplemented by any subsequent Quarterly Reports on Form 10-Q or other filings with the SEC. Readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. The Company does not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this communication or to reflect the occurrence of unanticipated events except as required by law.

3